Kamada (KMDA) Operating Income (2012 - 2026)
Kamada's (KMDA) quarterly Operating Income came in at $7.0 million in Q1 2026, down 10.8% YoY from $7.8 million in Q1 2025, and down 17.55% on a QoQ basis from $8.4 million in Q4 2025.
Kamada (KMDA) Operating Income (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Operating Income data on file, last reported at $7.0 million in Q1 2026.
- Quarterly Operating Income fell 10.8% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 billion (up 57564.72% YoY) and the FY2025 annual result came in at $26.2 million, up 30.83% from the prior year.
- Operating Income declined to $7.0 million in Q1 2026, from $8.4 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $18.9 billion in Q2 2025 to a low of -$2.3 million in Q2 2022.
- A 5-year average of $1.5 billion and a median of $7.8 million in 2025 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2022 — Operating Income slumped 319.31% — and 2025, when it jumped 335520.44%.
- Tracing KMDA's Operating Income over 5 years: stood at $4.0 million in 2022, then slumped by 30.91% to $2.8 million in 2023, then jumped by 247.41% to $9.6 million in 2024, then fell by 12.56% to $8.4 million in 2025, then slipped by 17.55% to $7.0 million in 2026.
- The last three Operating Income figures came in at $7.0 million (Q1 2026), $8.4 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Kamada | 455.98 Mn | 426.51 Mn | 22.47 Mn | 9.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.51 Mn |
| Mar 31, 2026 | 6.95 Mn |
| Dec 31, 2025 | 8.43 Mn |
| Sep 30, 2025 | 12.32 Mn |
| Jun 30, 2025 | 18.93 Bn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 9.64 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Jun 30, 2024 | 5.64 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 2.78 Mn |
| Sep 30, 2023 | 4.37 Bn |
| Jun 30, 2023 | 2.63 Mn |
| Mar 31, 2023 | 289.00 Mn |
| Dec 31, 2022 | 4.02 Mn |
| Sep 30, 2022 | 2.56 Bn |
| Jun 30, 2022 | -2.29 Mn |
| Mar 31, 2022 | 246,000.00 |
| Dec 31, 2021 | -3.30 Mn |
| Sep 30, 2021 | -804,000.00 |